
Building Market Presence, Partnerships and Launch Excellence
At Shionogi, we are committed to improving global health through innovation, collaboration and scientific excellence. As our European presence continues to grow, we are strengthening our regional commercial capabilities to support successful product launches and long-term market impact.
We are now seeking a Regional Key Account Manager to lead and develop our activities across the Benelux region (Netherlands, Belgium and Luxembourg). This is a pivotal role with responsibility for shaping market strategy, preparing for future launches and building strong partnerships across complex healthcare systems.
Why Join Shionogi?
Shionogi offers a purpose-driven, agile environment where individuals are empowered to make a meaningful impact. This role provides high exposure across the European organisation, close collaboration with senior leaders, and the opportunity to play a key role in establishing and growing our commercial footprint in Benelux.
About the Role
As Regional Key Account Manager, you will lead commercial execution and market development across the Benelux region, with a strong focus on pre-launch and launch readiness.
Key responsibilities include:
What Are We Looking For?
We are looking for a commercially experienced and strategically minded professional who is comfortable operating with autonomy in a complex, evolving environment.
You will bring:
Join Us
Join Shionogi and play a defining role in shaping our future across the Benelux region. If you are motivated by launch excellence, partnership-driven growth and long-term impact in healthcare, we would welcome your application.

Since 1878, we have been committed to developing new treatments to improve patients' lives worldwide. We are helping to address global health challenges such as antimicrobial resistance and COVID-19.
Since the 1950s, we have discovered and introduced several novel antibiotics, as well as innovative medications for HIV and influenza. Today, we are developing an investigational oral antiviral for COVID-19 and advancing clinical programs in Fragile X syndrome, acute ischemic stroke as well metabolic disorders and oncology.
Our team is driven to impact patient lives. Our partnerships with industry, government agencies, biotech companies and academia help to advance science with the urgency that today's health challenges demand. Through a combination of in-house discovery and strategic partnerships, we continue to deliver firsts for patients in the U.S. and worldwide.
See our community guidelines: https://bit.ly/4n3Jhe4